Literature DB >> 34040184

Promising anti-IL-6 therapy for atherosclerosis.

Irene Fernández-Ruiz1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34040184     DOI： 10.1038/s41569-021-00575-8

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial.

Authors:  Paul M Ridker; Matt Devalaraja; Florian M M Baeres; Mads D M Engelmann; G Kees Hovingh; Milana Ivkovic; Larry Lo; Douglas Kling; Pablo Pergola; Dominic Raj; Peter Libby; Michael Davidson
Journal:  Lancet       Date:  2021-05-17       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.